March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Optimization Of A Synthetic Biomimetic Hydrogel Intended For Myopia Control Through Scleral Regeneration
Author Affiliations & Notes
  • Mariana Garcia
    Vision Science,
    University of California, Berkeley, Berkeley, California
  • Amit K. Jha
    Bioengineering,
    University of California, Berkeley, Berkeley, California
  • Kevin E. Healy
    Bioengineering,
    University of California, Berkeley, Berkeley, California
  • Christine F. Wildsoet
    Vision Science,
    University of California, Berkeley, Berkeley, California
  • Footnotes
    Commercial Relationships  Mariana Garcia, None; Amit K. Jha, None; Kevin E. Healy, None; Christine F. Wildsoet, None
  • Footnotes
    Support  EY019628
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 3459. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mariana Garcia, Amit K. Jha, Kevin E. Healy, Christine F. Wildsoet; Optimization Of A Synthetic Biomimetic Hydrogel Intended For Myopia Control Through Scleral Regeneration. Invest. Ophthalmol. Vis. Sci. 2012;53(14):3459.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To optimize the formulation of a synthetic, injectable biomimetic matrix for growing mammalian scleral fibroblasts, with the ultimate goal of developing a material for rehabilitating the myopic sclera. This matrix is a thermoresponsive enzymatically-degradable semi-interpenetrating polymer network (edsIPN) cleavable by native matrix metalloproteinases. The semi-interpenetrating chain is grafted with RGD-containing 15-amino acid sequences derived from bone sialoprotein (bsp-RGD(15)), which serve as integrin binding sites.

Methods: : A series of edsIPNs was synthesized via redox radical addition polymerization, varying in crosslinker concentration from 1-4 mg/ml, and in bsp-RGD(15) concentration, from 0-210 μM. The complex modulus of each formulation was measured with parallel plate rheology, and their biocompatibility examined using scleral fibroblasts isolated from a 4 day-old pigmented guinea pig, which were seeded on the edsIPNs and cultured for 7 days. Cell viability was qualitatively assessed with CalceinAM and Ethidium homodimer (Invitrogen), and cell morphology was further examined by staining the actin fibers with rhodamine-conjugated phalloidin. Cell proliferation rates were measured with Alamar Blue (AbDserotec).

Results: : Mechanical characterization: The edsIPNs underwent phase transitions at ~33 oC. Moduli increased with increasing crosslinker concentration (1 to 4 mg/ml), ranging from ~70 Pa to ~1 kPa at 37 oC. Cell viability, morphology & proliferation: Cells seeded on 0 μM bsp-RGD(15) gels formed clumps and retained a rounded shape, while cells on gels with 105 and 210 μM bsp-RGD(15) spread well and displayed stable cytoskeletons. The same gels lead to better proliferation and morphology with increasing gel stiffness. Gels with an intermediate concentration (105 μM) of bsp-RGD(15) supported the highest number of viable cells.

Conclusions: : Stiffer gels with an intermediate concentration of bsp-RGD(15) yielded optimal cell proliferation and spreading. An intermediate crosslinker concentration (2 mg/ml), satisfies our requirement that the gel be injectable while supporting good cell adhesion and proliferation.

Keywords: myopia • sclera • regeneration 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×